Cargando…
2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea
Familial hypercholesterolemia (FH) is the most common monogenic disorder. Due to the marked elevation of cardiovascular risk, the early detection, diagnosis, and proper management of this disorder are critical. Herein, the 2022 Korean guidance on this disease is presented. Clinical features include...
Autores principales: | Lee, Chan Joo, Yoon, Minjae, Kang, Hyun-Jae, Kim, Byung Jin, Choi, Sung Hee, Jeong, In-Kyung, Lee, Sang-Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515735/ https://www.ncbi.nlm.nih.gov/pubmed/36212743 http://dx.doi.org/10.12997/jla.2022.11.3.213 |
Ejemplares similares
-
2022 Consensus statement on the management of familial hypercholesterolemia in Korea
por: Lee, Chan Joo, et al.
Publicado: (2022) -
Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Suh, Dong Hoon, et al.
Publicado: (2018) -
Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 2020
por: Kim, Hyoeun, et al.
Publicado: (2022) -
Fracture Liaison Service in Korea: 2022 Position Statement of the Korean Society for Bone and Mineral Research
por: Lim, Jae-Young, et al.
Publicado: (2023) -
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Lee, Shin-Wha, et al.
Publicado: (2017)